Bellevue Group Ag Alkermes Plc. Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $142,602 - $167,362	-6,144 Reduced 25.45%	18,000 $433,000
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $738,355 - $910,638	-27,968 Reduced 53.67%	24,144 $653,000
Q4 2023 Feb 14, 2024	SELL	$23.37 - $28.68 $691,471 - $848,583	-29,588 Reduced 36.22%	52,112 $1.45 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $495,950 - $588,525	17,500 Added 27.26%	81,700 $2.56 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $726,397 - $832,874	28,700 Added 80.85%	64,200 $1.81 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $778,870 - $931,520	35,500 New	35,500 $927,000
Q2 2022 Aug 11, 2022	BUY	$26.4 - $30.54 $850,080 - $983,388	32,200 Added 42.93%	107,200 $3.19 Million
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $1.73 Million - $2.1 Million	75,000 New	75,000 $1.97 Million
Q1 2020 May 14, 2020	SELL	$13.06 - $21.24 $2.2 Million - $3.58 Million	-168,400 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $2.91 Million - $3.66 Million	168,400 New	168,400 $3.44 Million
Q3 2018 Nov 13, 2018	SELL	$38.6 - $46.12 $1.26 Million - $1.51 Million	-32,650 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$40.56 - $51.36 $740,220 - $937,320	-18,250 Reduced 35.85%	32,650 $1.34 Million
Q1 2018 May 09, 2018	SELL	$53.61 - $67.26 $42,888 - $53,808	-800 Reduced 1.55%	50,900 $2.95 Million
Q4 2017 Feb 14, 2018	SELL	$47.69 - $55.39 $209,836 - $243,716	-4,400 Reduced 7.84%	51,700 $2.83 Million
Q3 2017 Nov 13, 2017	SELL	$49.16 - $54.45 $4.01 Million - $4.44 Million	-81,500 Reduced 59.23%	56,100 $2.85 Million
Q2 2017 Aug 14, 2017	BUY	N/A	137,600	137,600 $7.98 Million

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$865 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$564 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$386 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$376 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$273 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account